Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation
Yosuke Togashi, Hiroyoshi Nishikawa
Current topics in microbiology and immunology (2017), pp. 3-27
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Yosuke Togashi, Kohei Shitara, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 6, pp. 356-371
Closed Access | Times Cited: 1201
PD-1+regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada, Yosuke Togashi, Christopher Tay, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 20, pp. 9999-10008
Open Access | Times Cited: 796
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR -mutated non–small cell lung cancer
Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, et al.
Science Immunology (2020) Vol. 5, Iss. 43
Closed Access | Times Cited: 211
Regulatory T cells: a potential target in cancer immunotherapy
Kohei Shitara, Hiroyoshi Nishikawa
Annals of the New York Academy of Sciences (2018) Vol. 1417, Iss. 1, pp. 104-115
Open Access | Times Cited: 206
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Navid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1440-1440
Open Access | Times Cited: 184
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
Yasuko Tada, Yosuke Togashi, Daisuke Kotani, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 174
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 50
Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanoma
Wenyi Huang, Byeong Seop Kim, Yichi Zhang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4512-4530
Closed Access | Times Cited: 27
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang‐Kyou Lee
Immune Network (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 115
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
Umar Mehraj, Rais A. Ganai, Muzafar A. Macha, et al.
Cellular Oncology (2021) Vol. 44, Iss. 6, pp. 1209-1229
Closed Access | Times Cited: 99
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Navid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, et al.
(2021)
Open Access | Times Cited: 62
Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting
Sonia Aristín Revilla, Onno Kranenburg, Paul J. Coffer
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
Tomofumi Watanabe, Takamasa Ishino, Youki Ueda, et al.
Cancer Science (2023) Vol. 114, Iss. 5, pp. 1859-1870
Open Access | Times Cited: 25
Antibody-based cancer immunotherapy by targeting regulatory T cells
Quanxiao Li, Jun Lu, Jinyao Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Toward an understanding of regulatory T cells in COVID‐19: A systematic review
Mahsa Rahimzadeh, Nadereh Naderi
Journal of Medical Virology (2021) Vol. 93, Iss. 7, pp. 4167-4181
Closed Access | Times Cited: 46
<p>DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses</p>
Huimin Dan, Shanshan Zhang, Yongning Zhou, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 10903-10916
Open Access | Times Cited: 51
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30
The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases
Chao Yang, Mingjun Wu, Min You, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 30
CD4+ T cells in obesity and obesity-associated diseases
Yueshui Zhao, Ling Lin, Jing Li, et al.
Cellular Immunology (2018) Vol. 332, pp. 1-6
Closed Access | Times Cited: 35
Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions
Dean J. Naisbitt, Anna Olsson‐Brown, Andrew Gibson, et al.
Allergy (2019) Vol. 75, Iss. 4, pp. 781-797
Open Access | Times Cited: 30
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer
Akinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Gastric Cancer (2020) Vol. 23, Iss. 5, pp. 893-903
Open Access | Times Cited: 29
Role of CD4+CD25+FOXP3+TRegcells on tumor immunity
Agustinus Darmadi Hariyanto, Tiara Bunga Mayang Permata, Soehartati Gondhowiardjo
Immunological Medicine (2021) Vol. 45, Iss. 2, pp. 94-107
Open Access | Times Cited: 25
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
Jiaqi Liang, Guoshu Bi, Guangyao Shan, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 19
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01
Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 208-220
Open Access | Times Cited: 18
Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
Bingyu Wang, Zaibo Zhang, Wenbo Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114180-114180
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top